22 Jul TPS Research Report- GANX Gain Therapeutics
GANX- Gain Therapeutics $4 area Shares outstanding 12 million IPO 2021 at $11 per share Management owns 25%, a few other large players about 15%. Estimated real float about 2 million shares of the 12 million GAIN went public last year at 11, ran to 18 on good news and...